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ABSTRACT
For the Library of Integrated Network-based Cellu-
lar Signatures (LINCS) project many gene expres-
sion signatures using the L1000 technology have
been produced. The L1000 technology is a cost-
effective method to proﬁle gene expression in large
scale. LINCS Canvas Browser (LCB) is an interac-
tive HTML5 web-based software application that fa-
cilitates querying, browsing and interrogating many
of the currently available LINCS L1000 data. LCB im-
plements two compacted layered canvases, one to
visualize clustered L1000 expression data, and the
other to display enrichment analysis results using
30 different gene set libraries. Clicking on an ex-
perimental condition highlights gene-sets enriched
for the differentially expressed genes from the se-
lected experiment. A search interface allows users
to input gene lists and query them against over 100
000 conditions to ﬁnd the top matching experiments.
The tool integrates many resources for an unprece-
dented potential for new discoveries in systems biol-
ogyandsystemspharmacology.TheLCBapplication
is available at http://www.maayanlab.net/LINCS/LCB.
Customized versions will be made part of the http://
lincscloud.organdhttp://lincs.hms.harvard.eduweb-
sites.
INTRODUCTION
Gene expression-based high-throughput screening
Gene expression-based high-throughput screening (GE-
HTS) has the potential to transform biomedicine and ac-
celerate drug discovery by linking many bioactive molecu-
lar perturbations to their cellular phenotypes through the
molecular regulatory mechanisms those perturbations in-
duce (1,2). GE-HTS was applied to identify potentially use-
ful drugs to treat diseases such as leukemia (3) and skeletal
muscle atrophy (4), to identify heat shock protein (HSP)
(5) and PDGFR pathway inhibitors (6), to suggest drug
repositioning strategies (7) and to assist with drug resis-
tance strategies (8). GE-HTS data is designed for reuse.
Gene expression changes in response to perturbations are
distilledintoasetofdifferentiallyexpressedgenesignatures.
This enables the query of an input gene list against thou-
sands of signatures collected by GE-HTS. The first imple-
mentation of a GE-HTS platform was reported in a semi-
nal publication in Science in 2006 by Lamb et al. (9). The
projectwastermedtheConnectivityMap(CMAP).CMAP
data was collected from four human cell lines treated with
∼1300 drugs, including many Food and Drug Adminis-
tration (FDA) approved, in different concentrations. Sub-
sequently to those treatments, genome-wide gene expres-
sionmessengerribonucleicacid(mRNA)profilingwascon-
ducted after 6 h using the then widely popular Human
Affymetrix U133 microarray platform. The results are de-
livered through a web-based query tool where users can en-
ter their own lists of up- and down-regulated genes and re-
ceive matched experiments. This tool and the data are avail-
able freely to registered users at https://www.broadinstitute.
org/cmap/. The idea behind CMAP was well received and
led to the creation of a new and more extensive version of
CMAP.
LINCS and the L1000 technology
The Library of Integrated Network-based Cellular Signa-
tures (LINCS) project is a Common Fund program ad-
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ministrated by the National Institutes of Health (NIH).
The funds for this project enabled the generation of ap-
proximately one million gene expression profiles using the
L1000 technology. The L1000 technology was developed
for the new version of CMAP by the same group that de-
veloped the original CMAP at the Broad Institute. The
L1000 technology is a high-throughput method to estimate
genome-widemRNA expression.TheL1000 platformmea-
sures only about 1000 genes in each experiment. The rest
of the transcriptome, approximately 22 000 genes, are es-
timated by a model built from computational processing
of thousands of gene expression datasets from Gene Ex-
pression Omnibus (GEO) (10). The rationale behind this
model is that gene expression data contain high degree of
statistical dependencies between measured variables (mR-
NAs) and the selected 1000 landmark genes would cap-
ture most of the information contained within the entire
transcriptome. This assertion has been benchmarked with
gene expression data profiled using Affymetrix whole tran-
scriptome microarrays including the datasets that were de-
veloped for creating the first version of CMAP (9). Such
benchmarking activity is not part of the software develop-
ment project described in detail here. The L1000 platform
assay starts with amplifying mRNAs from crude cell lysates
using ligation mediated amplification (11). Probes contain
an upstream part and a downstream part. Both parts are
made of gene specific sequences. Probes are annealed to re-
versely transcribed complementary deoxyribonucleic acid
(cDNAs), created from the isolated mRNAs, and then lig-
ated by a taq ligase. Probes are then polymerase chain-
reaction amplified and hybridized to barcoded Luminex
beads through the probes’ gene specific barcode region.
The hybridized beads are then detected and quantified us-
ing the Luminex FLEXMAP 3D
R  technology (12). This
technology utilizes laser beams to detect the identity of the
differentially-dyed beads and to measure the density of the
hybridized probes on each bead. Besides landmark genes,
an additional 80 invariantly expressed transcripts are mea-
sured to calibrate and normalize overall gene expression
measurements in each plate. The reduced number of vari-
ables required to estimate the entire transcriptome keeps
the cost low. This makes the L1000 technology suitable for
GE-HTS and for fulfilling the aim of LINCS: cataloging
changes in gene expression that occur when cells are ex-
posed to many perturbing agents.
Description of the L1000 data
So far the data that has been collected and made available
by the L1000 technology comprise 22 412 unique pertur-
bations applied to 56 different cellular contexts including
human primary cell lines and human cancer cell lines. 16
425 of the perturbations are chemical reagents including
drugs,ligandsandothersmallmoleculesappliedatdifferent
time points and doses. 5806 of the perturbations are genetic
perturbations including knockdowns and over-expression
of single genes. The knockdown experiments utilize RNAi
technology and multiple miRNAs are employed to target
the same gene to reduce potential off-target effects. The to-
tal number of gene expression profiles measured to date
adds up to about a million. Since all experiments were done
onhumancellsusingwelldefinedandorganizedsetsofper-
turbations,usingthesameplatform,itispossibletodevelop
methods that would be able to produce collective mean-
ingful searches and visualization capabilities for this large
dataset.
The challenge of data analysis and data visualization of the
L1000 dataset
The L1000 dataset can be considered as a big matrix where
the rows are the 22 268 genes and the columns are the mil-
lion perturbations. Such a large dataset presents new chal-
lenges to computational systems biologists who aim to an-
alyze and visualize Big Data. Standard methods such as
principle component analysis (13) or hierarchical cluster-
ing (14) do not scale up well when thousands of conditions
are considered. One common method for visualizing large
scale data is ball-and-stick network diagrams. These dia-
grams are known to become meaningless once their size is
>∼100 nodes and ∼200 links. For developing the LINCS
Canvas Browser (LCB), we first divided the data by batch
andcell-line.Abatchisacollectionofexperimentsthatwere
processed by theL1000 in oneexperimental run, eachbatch
typically contain ∼3000 expression profiles where each ex-
perimental condition is repeated typically four times. We
then implemented a compact data visualization strategy us-
ing layered canvases that are made of two-dimensional pro-
jections of a continuous grid (torus). With this method we
are able to cluster and visualize up to 1000 different re-
lated L1000 conditions at once on the same canvas. The
canvas concept is similar to self-organizing maps (15)a n d
was previously implemented to visualize gene and protein
expression changes of mouse embryonic stem cells under-
going differentiation (16,17), and for performing gene- and
drug-set enrichment analyses (18). Recently, a similar ap-
proach was implemented to visualize transcription factor
co-localization from the ENCODE dataset (19).
Gene set enrichment analyses
Gene-set enrichment analysis provides a way to examine
potential biological functions for lists of genes (20). It
is a straightforward approach to associate an L1000 per-
turbation signature with the molecular mechanisms that
such perturbation induced in the specific experimental con-
text. Gene-set enrichment analysis computes the overrep-
resentation of a predefined gene-set for an input gene-set
(21). The analysis compares the input gene-set with a li-
brary of related gene-sets sharing the same type of func-
tion (21). For example, a gene set library can be made
of targets of transcription factors extracted from ChIP-
seq studies (22), substrates of a protein kinase collected
from kinase-substrate phosphorylation interactions from
the literature (23), or members of a pathway from pathway
databases such as KEGG (24), BioCarta (25), Reactome
(26) or WikiPathways (27). Many web-based or desktop en-
richment analysis tools have been developed including the
popular tools: GSEA-P (20), DAVID (28), FatiGO (29),
g:Profiler (30), INMEX (31), GeneTrail (32), WebGestalt
(33), Lists2Networks (34)a n dE n r i c h r( 35). With all these
tools, users need to provide their own differentially expres-
sion gene sets as the input. In addition to accepting inputNucleic Acids Research, 2014, Vol. 42, Web Server issue W451
gene lists for analysis, LCB has many lists preloaded, and
enrichment analysis can be performed in one click.
There are several methods to compute enrichment when
assessing the overlap between gene-sets (21,36). Some ex-
amples are the Fisher’s exact test (37), Gene Set Enrich-
ment Analysis (GSEA) (20) and Random-Sets (RS) (38).
The Fisher exact test places gene sets in a 2 × 2 contingency
table.Theentriesinthistablearethedifferentiallyexpressed
genes, the overlapping genes with a gene-set from the gene-
set library, the genes from the gene-set from the library that
do not overlap and all genes from the expression platform
or the gene-set library. The test then computes overrepre-
sentation of the overlap assuming a hyper-geometric distri-
bution. GSEA uses a Kolmogorov–Smirnov test statistic to
compute the enrichment score of a gene-set for a ranked list
ofdifferentiallyexpressedgenes.GSEAemploysapermuta-
tiontesttocalculatetheP-valueoftheenrichmentscore.RS
calculatestheenrichmentscoreforagenesetusingasimilar
method to the Welch’s t-test statistic. RS also uses a permu-
tation test to computes P-values. The permutation tests re-
quired by GSEA, RS and few other methods are more dif-
ficult to implement for a light-weight web-based software
application such as LCB because they take a long time to
execute. Hence, we chose the Fisher’s exact test for the ini-
tial implementation for computing gene-set enrichment for
LCB. Since LCB computes many enriched scores for many
conditions, using many gene-set libraries, the Benjamini–
Hochberg method to correct the P-values for multiple hy-
potheses testing is also implemented (39). The LCB is made
of two web pages: the search interface and the browse inter-
face. The search interface enables users to enter lists of up
anddo wnregula tedgenesandsearchf orma tchedperturba-
tions presented as a list of the 50 most similar experiments
with links to the browse interface (Figure 1). The browse
interface visualizes LINCS L1000 experiments and enrich-
ment analysis results using two canvas layouts, one that vi-
sualizes the clustered L1000 experiments and one that visu-
alizes the enrichment results (Figure 2).
MATERIALS AND METHODS
The overall data-assembly workflow for the browse inter-
face (Supplementary Figure S1) and the workflow for de-
veloping the search engine (Supplementary Figure S2) are
provided as supporting figures. Detailed explanation of the
methods used to create the various components of the web
server software is provided below.
The experiment canvases
Eachexperimentcanvasvisualizesallexperimentsforapar-
ticular cell line in a specific batch. Each tile represents one
experimental condition and similar experiments are placed
together on the canvas. The similarity between experiments
is calculated from the Z-score signatures of the 1000 mea-
suredgenesusingPearson’scorrelation.AZ-scoresignature
is a vector of moderated Z-scores calculated by the CMAP
group at the Broad Institute from the replicates of an ex-
perimental condition as it compares with the population
background.‘Moderated’meansthattheZ-scorestakeinto
account the quality of each replicate and give low weight
to bad quality replicates when averaging them. Z-score sig-
natures were downloaded using LINCS L1000 application
programming interface.
The Network2Canvas algorithm (18) is applied to com-
pute canvas layouts. This algorithm clusters experimental
conditionsbasedontheirsimilarityusingsimulatedanneal-
ing where each experiment is represented by a canvas tile.
The canvases are then rendered by HTML SVG elements
thatarecreatedandmanipulatedusingtheD3JavaScriptli-
brary(40).Fourviewsareimplementedtovisualizethedata
fromdifferentperspectives.Withintheaveragechangeview,
the tiles are colored by their average change values (Fig-
ure 3A). Bright red indicates high signature strength, or in
other words, more overall average change from the control.
A slider below the canvas controls the contrast between the
darkestandlightestcolors.Thisfeaturecanbeusedtohigh-
lightthemostsignificantperturbations.Thetimepointview
colors the canvas by the time points and a legend beneath
showsmappingbetweencolorsandtimepoints(Figure3B).
The dose view colors canvases by dose level and has a simi-
lar legend as the time point view. The Drug view colors tiles
by drugs or ligand types, and a dropdown menu beneath
the canvas allows users to highlight tiles of the same drug
or ligand perturbations (Figure 3C). The canvas is interac-
tive. Mouse-hovering on a tile causes a red box to appear in
the middle, displaying detailed information of the selected
experimental condition. Clicking on a tile invokes gene-set
enrichment analysis applied to the differentially expressed
genes of the clicked tile, and the results are shown on the
right panel gene-set library canvas (Figure 3D).
The gene-set library (enrichment) canvases
A gene-set library canvas visualizes all gene-sets in a gene-
set library. Each tile represents a gene-set and similar gene-
sets are placed nearby on the canvas. LCB includes 30 gene-
set libraries that were borrowed from the Network2Canvas
and Enrichr applications (18,35). These libraries are di-
vided into six categories: transcription, pathways, ontolo-
gies, diseases/drugs, cell-types and miscellaneous. The key
information about each gene-set library is provided in Ta-
ble 1. More details about the construction of each gene-set
library can be found in the article that describes the soft-
waretoolEnrichr(35).Canvaseswerecreatedfromgene-set
libraries using the Sets2Networks algorithm (41)a n dt h e n
the Network2Canvas algorithm (42). Sets2Networks score
set similarity by considering gene occurrence across the en-
tire library of sets. The brightness is computed for each
tile based on its similarity to its eight neighbors. The final
brightness is adjusted for each gene set library to balance
the overall brightness. The enrichment analysis in LCB im-
plements the Fisher exact test to compute enrichment (36).
To integrate the enrichment analysis canvases in LCB, a lis-
tener function listens to click events. These events are regis-
tered to each tile on the experiment canvases. When a user
clicks on a tile, the listener function is invoked, and then the
function passes the differentially expressed genes of that tile
totheenrichmentcanvas.Theenrichmentcanvasthentakes
the genes it just received, performs the enrichment analysis,
anddisplaystheresult.DifferentenrichmentcanvasescouldW452 Nucleic Acids Research, 2014, Vol. 42, Web Server issue
Figure 1. LCB search interface. Two textboxes are available to insert lists of up and down regulated genes. The search interface provides a link to the
Enrichr software. Clicking this button passes the input gene lists to Enrichr for independent enrichment analysis in a new web page. The Example button
fills the textboxes with sample lists. The Aggravate/Reverse slider swaps the up list with the down list so that the search is done in reverse mode. The result
panel displays the top 50 matching experiments in a table where only 10 entries are displayed per page. The screenshot is from Case Study 1: searching for
perturbations that could potentially reverse breast cancer progression and recurrence given a pre-compiled list of 374 breast cancer prognosis biomarker
genes.
be selected by the dropdown menu on the top of the enrich-
ment canvases.
Searching for and visualizing specific perturbations
A specific perturbation could be searched for using the
search bar above the canvas viewers within the browse in-
terface. An experiment is described in the format of ‘per-
turbation, dose, time-point, and cell-line’. The search bar
supports ‘*’ wildcards. For example, if we want to search
for all experiments that use the MCF10A cell line, have a
perturbation name that ends with ‘atinib’ and a time-point
of 6 h we can use the search query ‘*atinib * 6 h MCF10A’.
Selection of a matched experiment on the dropdown menu
would visualize the experiment in the appropriate canvas
and show its enrichment analysis results in a table (Figure
4).
Web communication protocols
LCBrequestsdataforcanvaseson-the-flyusingAJAXcalls.
LCB sends an AJAX request when a user selects a new
batch.Aserver-sidePHPscriptreadsthisrequestandsends
back the requested JSON file that describes the canvas as
plain text file. LCB interprets the file into JavaScript arrays
using the eval function. Similarly, a second server-side PHP
script handles the gene-set library requests and sends back
the gene-set canvases data for visualization.
The search interface
LCB contains a search engine interface where users can en-
ter their own input gene-lists to search against the differ-
entially expressed gene lists from the L1000 dataset that
was processed for LCB containing ∼150 000 experimen-
tal conditions. Three text files are created from the entire
L1000 dataset for the search purpose: (i) up genes file, (ii)
down genes file and (iii) up/down gene file. Each line in
t h e s efi l e ss t o r e su po r /and down genes for one experimen-
tal condition and all the experiments are included in each
of these files. The organization within this file is maximized
forqueryefficiencybypreloadingthefileintotheserverside
code at compile time. Once a user clicks the search button,
LCB posts the user input list/s with the description tags to
a server-side PHP script. The PHP script parses the gene
lists and determines which text file to use based on the de-
scription tags. The parsed lists are passed to a Python script
for the actual query process. The Python script compares
the overlap between the input list/s and the gene lists of
each experiment, and returns the top 50 matched experi-
ments with the highest overlap. Since the up and down gene
lists in the L1000 background signature dataset are equal in
length, a simple overlap computation is fast and accurate.
The overlap score is calculated as follows: |Dup ∩ Lup|/|Lup|
for up gene set input query Dup; |Ddown ∩ Ldown|/|Ldown| for
down gene set input query Ddown; and (|Dup ∩ Lup|+|DdownNucleic Acids Research, 2014, Vol. 42, Web Server issue W453
Figure 2. LCB browse interface. The browse interface has two types of canvases: The experiment canvases on the left and the enrichment canvases on the
right. The experiment canvases are made of all experiments for a specific cell line in a specific batch. Each tile represents one condition and the tiles are
arranged by gene content similarity. On the right the enrichment canvases display gene set enrichment results where each tile on these canvases represent a
gene-set from a gene-set library. Gene-sets are arranged on the canvas based on their gene content similarity and enriched terms for the selected condition
from the experiment canvas are highlighted in circles. Users can search for a specific condition using the search bar on the top, select a specific batch or
cell type using the dropdown lists near the experiment canvases, and select a gene-set library using the dropdown menu on top of the enrichment canvases.
∩ Ldown|)/(|Lup|+|Ldown|) for up and down gene-set query
where D is used to denote user input lists and L, L1000 lists.
The PHP script encodes the result into a JSON for-
mat and sends it back to LCB. An ‘Access-Control-Allow-
Origin:*’headerwassetinallPHPscriptstoenableuniver-
sal embedding of LCB. The search interface has two panels:
an input panel on the left and the results panel on the right
(Figure1).Intheinputpanel,therearetwotextboxestofill,
onefortheupgenelist andoneforthedowngenelist.Clear
buttons will clear all text in the input gene-list textboxes.
‘Up’ and ‘Down’ check boxes allow users to choose which
L1000 gene-list files to search. The search interface also has
an Enrichr button that passes the input gene lists to the En-
richr tool (43) for enrichment analysis in a new page. The
‘Example’ button fills the textboxes with sample gene lists
for demonstration purpose. The ‘Aggravate/Reverse’ slider
swaps the up list with the down list so that the search is
done in reverse mode. Aggravate means that the matching
perturbations, if applied in a similar experimental setting,
would potentially push cells in the same direction of the
gene expression changes that are observed by the user who
submitted the query. Reverse means that the matching per-
turbations, if applied in the same settings, will potentially
reverse the expression toward the control state. The result
panel will display the top 50 matched experiments in a ta-
ble. This table will display only 10 entries per page. Clicking
on ‘Previous/Next’ allows navigating through these pages.
Each entry is represented as a hyperlink and clicking on the
link will visualize the experiment and its enrichment analy-
sis results on the LCB browse interface (Figure 2).
Case Study 1: Searching for small molecules that could po-
tentially be tested for inhibiting breast cancer progression
Lauss et al. (44) developed a set of 374 genes associated
with breast cancer by compiling a consensus list from 44
published gene lists developed for breast cancer progno-
sis. This consensus list of 374 genes is also the first en-
try in GeneSigDB, a gene signature database created from
supporting tables of research publications (45). This 374
gene list was shown to be predictive of recurrence when
used as a biomarker-set to classify 1067 breast cancer pa-
tients. Since Lauss et al. (44) showed that probability of ex-
pression of these genes is associated with breast cancer re-
currence, we pasted the list into the ‘Up List’ text box of
the search interface of LCB, checked only the ‘Up’ check-
box, and switched the ‘Aggravate/Reverse’ slide-bar to ‘Re-W454 Nucleic Acids Research, 2014, Vol. 42, Web Server issue
Figure 3. Four views of the clustered experimental data. (A) Tiles represent individual conditions and are colored by their average change where bright red
indicates more change. A slider below the canvas controls contrast. (B) The time point view colors the canvas by time points. (C) The drug view colors tiles
by drug or ligand types, and a dropdown menu beneath the canvas allows users to highlight tiles of the same drug or ligand perturbations. (D) Gene-set
enrichment analysis results, applied to the differentially expressed genes of the clicked tile, are displayed on the MGI-MP gene-set library enrichment
canvas. Each tile on this canvas represents a gene-set, and circles highlight the enriched terms. Bright tiles represent high similarity among gene sets in the
local region of the bright tile. A list box on top of the canvas allows user to switch between 30 different gene set libraries. The canvases fold on themselves
such that the edges are connected to opposite edges forming a torus.Nucleic Acids Research, 2014, Vol. 42, Web Server issue W455
Table 1. Information about the 30 gene-set libraries used in LCB
Category Name Terms
Transcription Chip-X Enrichment Analysis (ChEA) Transcription factors
JASPAR + Transfac PWM Transcription factors
UCSC GenomeBrowser PWM Transcription factors
Histone Modifications ChIP-seq Histone modifications
Target Scan––MicroRNAs MicroRNAs
ENCODE Transcription Factors ChIP-seq Transcription factors
Pathway KEGG Pathways Pathways
WikiPathways Pathways
Reactome Pathways Pathways
Biocarta Pathways Pathways
PPI Hub Proteins Hub proteins
Kinase Enrichment Analysis (KEA) Kinases
Human Endogenous Complex Protein complexes
CORUM Protein complexes
Ontology Gene Ontology Biological Processes Biological processes
Gene Ontology Cellular Components Cellular components
Gene Ontology Molecular Function Molecular functions
MGI-Mammalian Phenotype-Top 4 Phenotypes
Disease/ drug Up-Regulated CMAP Top 100 Drugs
Down-Regulated CMAP Top 100 Drugs
GeneSigDB Pubmed IDs
OMIM Diseases Diseases
OMIM Expanded Diseases
VirusMINT––Virus–Host Interactings Viral proteins
Cell type Human Gene Atlas Human tissues
Mouse Gene Atlas Mouse tissues
Cancer Cell Line Encyclopedia Cancer cell lines
NCI-60 Cancer Cell Line Cancer cell lines
Miscellaneous HMDB Metabolites Chromosomal locations
PFAM Interpro––Protein Domains Metabolites
verse’ (Figure 1). After clicking the ‘Search’ button, the
top returned experimental conditions are: Tyrphostin AG
1478 applied to A375, a skin cancer cell-line; PD0332991
applied to MDAMB231 and MCF10A breast cancer cell
lines; Aminopurvalanol applied to PC3, a prostate cancer
cell-line; and a benzenesulfonamide derivative also applied
to PC3. Tyrphostin AG 1478 is an EGFR inhibitor, and
was already reported to inhibit proliferation and progres-
sion of human breast cancer cell-lines (46). PD0332991 is
a kinase inhibitor targeting CDK4/6 and was reported to
suppress proliferation of ER+ human breast cancer lines
(47). Aminopurvalanol is a CDK kinase inhibitor that ex-
erts its effects on the canonical MAPK pathway by sup-
pressing proliferation of several mammalian cell-lines in-
cluding MCF7, a human breast cancer cell-line (48). The
benezensulfonamidederivativeisabioactivesmallmolecule
of unknown targets and mechanisms. Among these top five
matched perturbations, PD0332991 is interesting since the
top matches were applied to breast cancer lines and there
are three of them. Clicking on the first PD0332991 matched
perturbation,theonethatwasappliedtoMDAMB231cells
at 2 m and gene expression was measured at 24 h, we
can see that the perturbation is highlighted on the exper-
iment canvas within the average change view. The color-W456 Nucleic Acids Research, 2014, Vol. 42, Web Server issue
Figure 4. Example for a search query using LCB. The search for all experiments that use the MCF10A cell line, have a perturbation name that ends with
‘atinib’ and a time-point of 6 h is applied with the query ‘*atinib * 6 h MCF10A’. Users can then select one of the entries to see their position within their
associated canvas.
ing of the perturbation indicates that it is not a strong
perturbation relative to the other perturbations applied to
the MDAMB231 cells within this same batch. The 10 m
PD0332991 perturbation, which is another top matched ex-
perimentforourquery,islocatedlefttothehighlightedper-
turbation, suggesting that there is high similarity in gene
expression changes induced signatures for these two pertur-
bations (Figure 5A). WikiPathways (27) enrichment analy-
sis of the down-regulated genes for this perturbation shows
high enrichment for ‘DNA replication’, ‘G1 to S cell cycle
control’ and ‘cell cycle’ (Figure 5B and C). This enrichment
result is consistent with the knowledge that PD0332991 is a
CDK inhibitor. Enrichment analysis using the MGI Mam-
malian Phenotype gene-set library suggests enrichment for
genes that when individually knocked out in mice can cause
‘abnormal cell cycle’ and ‘abnormal cell proliferation’, con-
firming that PD03322991 is likely attenuating cell prolif-
eration through inhibition of the cell cycle. For the top
matched perturbation: Tyrophostin AG 1478 the pertur-
bation appears relatively strong on the experimental can-
vas (Figure 5D). The WikiPathways enrichment analysis
of the down genes shows enrichment for the same cell cy-
cle related terms seen for PD0332991 as well as ‘MAPK
pathway’ terms which are not present in the PD0332991
WikiPathwaysenrichmentanalysis.Thisobservationiscon-
sistent with the notion that Tyrophostin AG 1478 inhibits
EGFR.TheMGIMammalianPhenotypeenrichmentanal-
ysis results suggest ‘abnormal cell cycle’ and ‘abnormal tu-
mor incidence’ as the two most highly enriched terms. This
is consistent with the knowledge about the anti-tumor ef-
fects of Tyrophostin AG 1478 (Figure 5E and F).
While the analysis so far confirms known drugs and their
mechanisms of action in cell-lines, LCB is useful for discov-
ering potential mechanisms for new drugs. The benezen-
sulfonamide derivative, the fifth drug on the list, has no
known targets or mechanisms. The experimental canvas
shows that this perturbation is relatively strong (Figure
5G). The WikiPathways enrichment analysis of the down
genes suggest the same three cell cycle related terms shown
for PD0332991 and Tyrophostin AG 1478, but also the
‘IL-3 and IL-7 pathways’. This suggests that this com-
pound may be related to a process that inhibits the ex-
pression of genes that belong to Interleukin-related path-
ways. The MGI Mammalian Phenotype enrichment analy-
sis points to tumor proliferation related terms but also con-
tain ‘abnormal blood cell’, which adds support for a poten-
tial role for this benezensulfonamide derivative to engage
with interleukin-related pathways, since interleukins are ex-
pressed in thehematopoieticsystem and disruption of these
pathways can lead to blood cell abnormalities (Figure 5H
and I).
Case Study 2: IL-1 and IL-6 Signaling in Macrophages
Jura et al. (49) profiled the transcriptional response of
human monocyte-derived macrophages to IL-1 or IL-6.
They concluded that IL-1 is a much stronger perturbagen
of macrophages than IL-6. The genes significantly up-
regulated by IL-1 were primarily cytokines, their receptors,
intracellular signaling molecules, and NF-kB family tran-Nucleic Acids Research, 2014, Vol. 42, Web Server issue W457
Figure 5. Visualization of enrichment analyses of selected perturbations from the results shown in Figure 1:( A–C) PD0332991; (D–F) Tyrophostin AG
1478 and (G–I) the Benezensulfonamide derivative.W458 Nucleic Acids Research, 2014, Vol. 42, Web Server issue
Figure 6. Top perturbations that match the top 100 genes significantly up-regulated by IL-1 (A)o rI L - 6( B) treatment of monocyte derived macrophages.
Figure 7. Canvases for the top ranked IL-1 perturbation: IL-1 applied to MCF7 cells at a concentration of 100 ng/lf o r3h .( A) The selected perturbation
is surrounded by similar perturbations which are either IL-1 or TNF-alpha treatments. (B) Visualization of the enriched terms using the MGI mammalian
phenotypes gene set library.
scription factors. We downloaded from the Gene Expres-
sion Omnibus the microarray data from this study (GEO
Accession GDS3005), which contained five control sam-
ples, five IL-1 treatment samples and five IL-6 treatment
samples. We averaged the expression values for probes that
mapped to the same gene and log2-transformed the expres-
siondata.Wethenrankedthegenesbysignificanceofdiffer-
ential expression using the t-test by comparing the IL-1 and
IL-6 to the control separately. Then we pasted the top 100
up-regulated genes into the ‘Up List’ textbox, clicked the
‘Up’ checkbox, set the slide-bar to ‘Aggravate’, and clicked
‘Search’.Nineofthe10mostsimilarperturbationswereIL-
1 treatments applied to various cell-lines at various concen-
trations and time points (Figure 6A). The other perturba-Nucleic Acids Research, 2014, Vol. 42, Web Server issue W459
tion,whichwasrankedeighth,wasaTNF-alphatreatment.
The top 24 most similar perturbations were exclusively IL-1
orTNF-alphatreatments.Thisisconsistentwiththenotion
that IL-1 and TNF-alpha act cooperatively to mediate a
similar inflammatory response and IL-1 is known to induce
TNF-alpha expression (50). We performed the same search
using the top 100 genes up-regulated by IL-6 and recovered
only one IL-6 treatment in the list of top 10 most similar
perturbations (Figure 6B). The weaker IL-6 signal from the
search results is consistent with the finding of Jura et al.
wheretheyconcludedthatIL-1inducesamuchstrongtran-
scriptionalresponsecomparedwithIL-6(49).Tofurtherex-
amine the molecular changes induces by the IL-1 treatment
for the most similar perturbations we clicked on to top en-
try from the returned results: IL-1 applied to MCF7 cells at
a concentration of 100 ng/l for 3 h. The left canvas shows
that the IL-1 perturbation clustered with similar perturba-
tions applied in the same batch to MCF7 cells (Figure 7A).
Neighboring perturbations on this canvas were other TNF-
alpha and IL-1 treatments at different time points and con-
centrations. Color intensity indicated that the matched per-
turbation we selected was moderately strong relative to the
otherperturbationsonthiscanvas.Ontheright-sideenrich-
mentcanvastheresultsforMGImammalianphenotypeen-
richmentanalysisshowenrichmentforimmunerelatedphe-
notypes for the up regulated genes (Figure 7B). These en-
riched terms are all consistent with the role of IL-1 in medi-
ating immune system function and inflammatory responses
(51,52). Enrichment analysis with ENCODE showed that
the top five enriched ChIP-seq experiments were for NF-
kB, which is consistent with the role of NF-kB in medi-
ating IL-1 induced transcriptional responses (53). Enrich-
ment analysis with the Cancer Cell Line Encyclopedia (54)
gene-set library, found enrichment for cancer cell lines de-
rivedfromhaematopoieticandlymphoidtissue,whichisex-
pected given the role of IL-1 in the immune system. How-
ever, the most highly enriched cell line was PANC0213, a
pancreatic cancer cell line. This finding supports a recent
study suggesting that IL-1 plays a key role in maintaining
an inflammatory microenvironment favorable for pancre-
atic tumor progression (55).
DISCUSSION AND CONCLUSIONS
The LCB application is still at early stages of development.
Customizable versions of the tool will be made available on
the http://lincscloud.org and http://lincs.hms.harvard.edu
websites. Besides adding the remaining available and newly
developed L1000 experiments, more gene set libraries will
be added to the enrichment analysis part. In addition, cel-
lular phenotype data such as proliferation rate and cell via-
bility results can be overlaid on the canvases as other layers
tovisualizeexpressionchangeswithcellularphenotypesun-
der various perturbations. Currently, LCB implements the
Fisher exact test for enrichment but this can be improved
with better and more accurate methods. With the L1000
data, enrichment analysis methods could be benchmarked
by examining, for example, how knockdowns of transcrip-
tion factors followed by expression can be matched with
gene-set libraries of the same transcription factors created
from ChIP-seq studies. Currently, LCB treats each exper-
imental condition separately. However, it might be better
for users to interact with consensus signatures that merge
all experiments for a specific perturbation into one meta-
signature. LCB represents an attempt to extract knowledge
from the L1000 LINCS rich dataset. However, since the
data and analysis methods within the LCB tool have not
been extensively tested and verified, at this time the tool
should be used with caution. User should use LCB to ex-
plore their data in the context of the L1000 data, without
conclusive interpretation of the results.
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